You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma

 

Online download statistics by month:

Online download statistics by month: June 2022 to February 2026

AbstractFullPdf
Jun 2022409427143
Jul 2022260265109
Aug 202219720153
Sep 202217419247
Oct 202218718759
Nov 202216917060
Dec 202213713740
Jan 202315415454
Feb 202314614854
Mar 202311411452
Apr 2023828340
May 202310210447
Jun 202310811044
Jul 202311011041
Aug 202310210738
Sep 202315015147
Oct 202311111244
Nov 202311912055
Dec 202310410657
Jan 2024848760
Feb 202411311346
Mar 202412812972
Apr 202410210460
May 202410710939
Jun 20249710748
Jul 202412913046
Aug 2024747342
Sep 2024636325
Oct 202410210434
Nov 202410510654
Dec 202410410648
Jan 2025727235
Feb 202521121230
Mar 2025747938
Apr 20259910151
May 202510110251
Jun 2025515326
Jul 2025110
Sep 2025110
Dec 2025550
Jan 2026001
Feb 2026110
Total475948561890